. This can be used for diagnosis in retrospect, but since at least two titres must be done at intervals of several days it is not much help in the diagnosis of the disease in an infant suffering from jaundice, when treatment may be a pressing matter.
The antenatal prediction of ABO hemolytic disease also has been virtually confined to the 'educated guess', until the recently published work of Tovey et al. (1962) . These workers have used the observations of Winstanley et al. (1957) , that group A pig cells absorb the haemolytic fraction of 'immune' anti-A but do not absorb the 'naturallyoccurring' anti-A, to devise a scheme for testing the sera of group 0 mothers during pregnancy, and in a large series have obtained a remarkably good prediction of the disease and also of its severity. Their observations are extremely interesting and the immunological basis for their results deserves further investigation, since it is not clear as yet that the antibody which is reacting with the AP cells is confined entirely to that which sensitizes the infant's cells. The basis for this comment arises from the fact that similar reactions were observed with Group A and B sera, although with less frequency, and yet the disease is not commonly found in infants born to mothers of these groups.
It is obvious from the foregoing that the final chapter has not been written on ABO hemolytic disease. Despite the recent increases in our knowledge the diagnosis is still often difficult to establish with certainty. Very often one is in the position of having to report that since no other antibodies can be detected the jaundiced infant is 'probably suffering from ABO hemolytic disease'. 
Indications
In our experience at the Hammersmith Hospital the need for exchange transfusion in haemolytic disease of the newborn due to ABO incompatibility does not frequently arise. In the past four and a half years we have given one or more exchange transfusions to 85 newborn infants suffering from Rh incompatibility, but only to 11 with ABO hxemolytic disease out of approximately 11,000 deliveries. We did not start treatment by exchange transfusion ofjaundiced infants without hmmolytic disease until the-beginning of 1959. In three and a half years since we have carried out one or more exchange transfusions on 46 such infants. All but two ofthese were prematurely born and 14 were infants admitted from the district. The aim of exchange transfusion in all three situations is the sameto prevent the accumulation of dangerous concentrations of unconjugated bilirubin within the susceptible cells of the central nervous system. It is well known that for several reasons the level of serum bilirubin is likely to be an imperfect guide to the level of intracellular bilirubin. It is frequently said that a serum bilirubin level of 20 mg/100 ml should not be exceeded, but Mollison & Cutbush (1954) showed that only one of 13 infants with bilirubin levels from 20 to 25 mg/100 ml, and five of 12 infants with levels between 25 and 29 mg/l00ml developed kernicterus. Thus many unnecessary exchange transfusions would be carried out if the avoidance of serum bilirubin levels above 20 mg/100 ml were strictly observed.
It is not always practicable to postpone transfusion until the serum bilirubin has reached the critical level; for instance fresh donor blood is not easily obtainable at night. We therefore try, by doing serum bilirubin estimations in the evening, to predict the bilirubin level the following morning. The greater the number of previous bilirubin determinations in an infant, the more reliable are predictions about future levels. The curve of serum bilirubin level against time is almost invariably concave downwards, and therefore extrapolating the line between the last two points will give a figure for bilirubin level which is very unlikely to be exceeded. It is clear, however, that some unnecessary exchange transfusions are carried out if the indication is based on prediction about future levels of serum bilirubin.
We try to prevent the serum bilirubin rising above 25 mg/100 ml in term babies, above 20 mg/ and 15 mg/100 ml in those below 1-2 kg. We use the Malloy & Evelyn (1937) method forestimating serum bilirubin and the figure of 25 mg/100 ml is based on Mollison's finding that at this level readings are about 30% higher than those of methods on which previous standards were based . The figure of 15 mg/100 ml for the smaller premature babies was chosen because of the occurrence of fatal kernicterus in three very immature infants whose bilirubin was about this level. This was before exchange transfusion for jaundiced infants without hmemolytic disease was practised at the Hammersmith Hospital. In fact we do not adhere rigidly to these figures. For instance, we do not exchange transfuse at these levels if the serum bilirubin curve is already flattening out at the third or fourth day or later in the case of premature infants. We are also influenced by the behaviour of the infant and are less inclined to exchange if the infant is vigorous and especially if he is feeding well. The latter may also be of significance in relation to bilirubin conjugation and excretion (Laurance & Hutchinson Smith 1962) .
It is a mistake to consider kernicterus as an all or none phenomenon. Infants may survive severe hyperbilirubinemia with high-tone deafness as the sole evidence of brain damage and conversely it seems reasonable to accept that in the first few days of life the danger of kernicterus is not imminent if the baby is not drowsy.
The question of unnecessary exchange transfusions is discussed by Trolle (1961) in a paper in which he compares the incidence in Denmark of known survivors of kernicterus following jaundice of varying oetiology in the neonatal period with the numbers of exchange transfusions carried out in a thousand consecutive live births at Rigshospitalet, Copenhagen. He has to make assumptions concerning the probable numbers of infant fatalities from kernicterus in relation to the numbers of survivors, and then calculates that about 4 premature babies with jaundice of unknown etiology leading to a serum bilirubin of over 20 mg/100 ml are transfused to save one from developing kernicterus, or 9 babies are transfused to save one if the figure of 20 mg/100 ml is strictly adhered to. Applying the same calculations to his figures of kernicterus survivors and exchange transfusions in cases of jaundice due to ABO incompatibility, 17 exchange transfusions are carried out to prevent one death from or survival with kernicterus.
Trolle's serum bilirubin determinations were performed by the micromethod of Jendrassik & Grof (1938) giving total bilirubin concentrations. Although we determine both conjugated and unconjugated bilirubin concentrations we have seldom found the level of the former above 1 or 2 mg/100 ml. Higher figures have occasionally occurred in the first or second day of life in very seriously affected babies (Hurdle & Walker 1963) and in a few others after the fourth day when the expected fall in total serum bilirubin did not take place. Measurement of total bilirubin concentration would therefore seldom lead to unnecessary exchange transfusions, especially when it is taken into account that conjugated bilirubin is bound to serum albumin, leaving the unconjugated pigment free to diffuse.
However, Trolle's figures for exchange transfusion in cases of jaundice of prematurity and ABO incompatibility greatly exceed ours, being 13 and 9 in 1,000 live births respectively, compared with 32 in 8,773 live births and 11 in 11,011 live births at the Hammersmith Hospitalan instance of one of the inexplicable differences in experience of neonatal jaundice between neonatal departments. If the Danish figures for the incidence of kernicterus were applicable to England, it would suggest that we were not carrying out many unnecessary exchange transfusions.
If there were some means of estimating tissue fluid, or better still cerebral intracellular bilirubin levels, the decision about exchange transfusion might be easier; nevertheless, it is clear that the type of experiment reported by Mollison & Cutbush in 1954 could not be repeated today.
Technique
We prefer the use of fresh heparinized donor blood, although the finding of hrmolysins creates a problem when the need for a transfusion is urgent in a case of ABO incompatibility. When stored blood is used we add 1,500 units of heparin and 5 ml of 1 00., calcium gluconate to the donor bottle before removing about half the plasma. Intravenous injections of calcium gluconate during the procedure are thus avoided.
The use of soft, flexible polyvinyl umbilical venous catheters has revolutionized the technique of exchange transfusion; venous spasm and clotting which used to result from movement of the stiff polythene catheters, very seldom occur and consequently the risk of portal phlebitis has been reduced (Tizard 1962 ). We do not use routine prophylactic antibiotic treatment, but instead take swabs for culture from the umbilical stump before spraying with Polybactrin powder. This is done before and after each transfusion and we are careful to remove any blood clot from the stump before a second exchange. The catheter is filled with heparin saline before being introduced and the proximal end occluded with the attached rubber bunga necessary precaution against air embolism, which has caused one fatality in our series. There is also a danger of air embolism 8 when the bung has been removed for estimation of venous pressure.
We have had one case of sudden unexpected death following exchange transfusion for which blood four days old had had to be used. On investigation potassium levels in both the donor's and baby's blood were found to be very high. But the chief immediate danger in exchange transfusion appears to be cardiac failure, and we routinely digitalize using lanatoside C 0 01 mg per kilogram of body weight as the initial dose. In avoiding cardiac failure it seems to be important to inject donor blood slowly and a large clock is placed in the operator's view to ensure that at least two minutes is taken to inject 20 ml of blood.
The venous blood withdrawn is usually red and perhaps the earliest sign of impending cardiac failure is a darkening of the colour towards cyanosis. When this occurs the transfusion is promptly stopped and restarted in an hour's time if the baby's condition has improved. We carry out most transfusions with the baby in an incubator, and in any case do not pinion the limbs. The removal of bandages fixing the baby's legs to a crucifix may precipitate cardiac failure (J A Davis, 1962, personal communication).
The risk of cardiac failure is more serious in 'topping-up' transfusions for subsequent anmmia in cases of hlmolytic disease of the newborn. In these cases we have found that intraperitoneal blood transfusions produce satisfactory rises in haemoglobin while obviating the risk of sudden expansion of the circulatory blood volume (Scopes 1963, to be published).
Trolie D (1961) Actapadlat. Stockh. 50, 392 Dr A D F Hurdle (Postgradutate Medical School, London) read a paper entitled Aplastic Anammia. For the report of a case of this condition see: Hurdle A D F & Walker A G (1963) Brit. med. J. i, 518
Meeting November 61962 A Laboratory Meeting was held at the Wright-Fleming Institute of Microbiology, St Mary's Hospital, London. Demonstrations were given.
Meeting February 5 1963 A Laboratory Meeting was held at the Royal Free Hospital, London. Demonstrations were given.
